ProJect Pharmaceutics GmbH

At ProJect Pharmaceutics, we transform chemical and biological ingredients into pioneering therapies. As specialists in formulation science and pharmaceutical process development, we bring deep expertise in recombinant proteins, ADCs and cytotoxics, and live virus vaccines. We do not just formulate drugs - we enhance their intrinsic value. Every day, we design optimized pharmaceutical formulations and delivery systems that maximize safety and application convenience. We develop cost-effective fill and finish processes, tailored for the formulation and delivery system of choice, and seamlessly scale from our pilot lab to large-scale commercial manufacturing. What sets us apart is our ability to develop Antibody Drug Conjugates (ADCs), combining advanced protein formulation and process know-how with cytotoxic drug expertise - a rare combination in the biopharmaceutical industry. Our new safety facilities (GMO S2 and BSL-2) in dedicated labs, together with our profound understanding of live virus formulation and processing, enables us to deliver precise solutions for these highly complex products. Our expertise: • Drug formulation development for all kinds of recombinant proteins and protein conjugates • High protein concentration formulations • Formulation & lyophilization process development for highly potent drugs, including ADCs • Downstream process development • Material compatibility assessment • Clinical administration and in-use studies • Robust lyophilization processes - efficient, optimized, and scalable • Formulation and lyophilization process development for live virus vaccines • Preclinical study material manufacturing • Technology-transfer & scale-up to GMP-manufacturing Our promise • Optimized formulations for biopharmaceuticals • Tailored manufacturing processes ready for transfer to GMP manufacturing • Development reports designed for seamless regulatory submission